A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Acute Lymphoblastic Leukemia
Related studies linked through entity extraction aliases.
Human CD19 Targeted T Cells Injection Therapy for Relapsed and Refractory CD19-positive Leukemia
- Status
- UNKNOWN
- Phase
- PHASE1
Study of huCART19 for Very High-Risk (VHR) Subsets of Pediatric B-ALL
- Status
- COMPLETED
- Phase
- PHASE2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- Status
- RECRUITING
- Phase
- PHASE2
CD19.CAR-multiVSTs for Patients With CD19+ B-ALL or NHL Undergoing Related Allogeneic HSCT (CARMA)
- Status
- WITHDRAWN
- Phase
- PHASE1
CLIC-1901 for the Treatment of Patients With Relapsed/Refractory CD19 Positive Hematologic Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
REALIB-LLA-2017: Idelalisib in Patients With Acute Lymphoblastic Leukemia
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
International Trial of Selumetinib in Combination With Dexamethasone for the Treatment of Acute Lymphoblastic Leukaemia
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study Of Two Inotuzumab Ozogamicin Doses in Relapsed/ Refractory Acute Lymphoblastic Leukemia Transplant Eligible Patients
- Status
- COMPLETED
- Phase
- PHASE4
Asparaginase Activity Monitoring (AAM) in Adult Patients With Acute Lymphoblastic Leukemia (ALL)
- Status
- TERMINATED
- Phase
- PHASE2
HLA 10/10 Matched Unrelated Donor vs Haploidentical Allogenic Hematopoietic Stem Cell Transplantation
- Status
- UNKNOWN
- Phase
- PHASE3
MT2017-45: CAR-T Cell Therapy for Heme Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Tisagenlecleucel vs Blinatumomab or Inotuzumab for Patients With Relapsed/Refractory B-cell Precursor Acute Lymphoblastic Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE3
Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Compassionate Use of CAR T Cells Targeting the CD19 Antigen and Containing the Inducible Caspase 9 Safety Switch
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Postural Control Under Different Cognitive Loads in Adult Survivors of Acute Lymphoblastic Leukemia and Age-Matched Healthy Individuals
- Status
- COMPLETED
- Phase
- N/A
Vyxeos(CPX-351) in Adults w R/R Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
Pharmacogenomics of Asparaginase Induced Hepatotoxicity
- Status
- RECRUITING
- Phase
- N/A